Micro Labs Ltd Introduces Trisopt: World’s First Triple Drug Fixed-Dose Combination for Glaucoma Management
Micro Labs Ltd Introduces Trisopt New Delhi (India), August 21: Micro Labs Ltd, a renowned pharmaceutical company, proudly announced the launch of Trisopt, the world’s first fixed-dose combination of Brimonidine, Timolol, and Brinzolamide ophthalmic suspension for glaucoma management. Trisopt is an indigenous development from Micro Labs, manufactured in their state-of-the-art facility located in Sikkim. Glaucoma […]
Continue Reading